Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN70,5470,561,74
Msft-0,19
Nokia3,59353,610,43
IBM0,04
Mercedes-Benz Group AG68,1268,14-0,38
PFE-0,97
18.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 10.05.2024 14:47:33
MediClin AG (MEDG.F, Frankfurt)
Závěr k 17.5.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
2,78 0,00 0,00 102
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.05.2024
Popis společnosti
Obecné informace
Název společnostiMediClin AG
TickerMED
Kmenové akcie:Ordinary Shares
RICMEDG.DE
ISINDE0006595101
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.03.2024 6 984
Akcie v oběhu k 31.03.2024 47 500 000
MěnaEUR
Kontaktní informace
UliceOkenstr. 27
MěstoOFFENBURG
PSČ77652
ZeměGermany
Kontatní osobaEnder Gulcan
Funkce kontaktní osobyHead of Investor Relations and Sustainability
Telefon 497 814 880
Fax49781488133
Kontatní telefon49 781 488 184

Business Summary: MediClin AG is a Germany-based company. The Company is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. It focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
Financial Summary: BRIEF: For the three months ended 31 March 2024, MediClin AG revenues increased 6% to EUR191.8M. Net loss decreased 78% to EUR1.4M. Revenues reflect Post Acute segment increase of 6% to EUR112.7M, Other Activities segment increase of 23% to EUR7M, Acute segment increase of 1% to EUR65.7M. Lower net loss reflects Acute segment loss decrease of 72% to EUR1.3M, Post Acute segment income increase from EUR2.9M to EUR5.9M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Hospitals, Clinics & Primary Care Services
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSGeneral Medical and Surgical Hospitals
NAICSSpecialty (except Psychiatric and Substance Abuse) Hospitals
NAICS2007General Medical and Surgical Hospitals
NAICS2007Specialty (except Psychiatric and Substance Abuse) Hospitals
NAICS1997General Medical and Surgical Hospitals
NAICS1997Specialty (except Psychiatric and Substance Abuse) Hospitals
SICGeneral Med'L/surgical Hospitals
SICSpecialty Hospitals Not Psych'Ric



  • Poslední aktualizace: 19.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardJan Liersch5122.11.201922.11.2019
Chairman of the Management Board, Chief Executive OfficerJoachim Ramming-01.08.202101.08.2021
Vice Chairman of the Supervisory Board, Employee RepresentativeHans Hilpert-13.03.200213.03.2002
Chief Financial Officer, Member of the Management BoardTino Fritz4401.09.201820.02.2018
Chief Operating Officer, Member of the Management BoardThomas Piefke-01.10.202301.10.2023